GB9701453D0 - Aminobenzophenones - Google Patents

Aminobenzophenones

Info

Publication number
GB9701453D0
GB9701453D0 GBGB9701453.4A GB9701453A GB9701453D0 GB 9701453 D0 GB9701453 D0 GB 9701453D0 GB 9701453 A GB9701453 A GB 9701453A GB 9701453 D0 GB9701453 D0 GB 9701453D0
Authority
GB
United Kingdom
Prior art keywords
alkyl
content
carbamoyl
alkoxycarbonyl
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9701453.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Priority to GBGB9701453.4A priority Critical patent/GB9701453D0/en
Publication of GB9701453D0 publication Critical patent/GB9701453D0/en
Priority to US09/341,923 priority patent/US6313174B1/en
Priority to HU0000678A priority patent/HUP0000678A3/hu
Priority to PCT/DK1998/000008 priority patent/WO1998032730A1/en
Priority to JP53149998A priority patent/JP4250204B2/ja
Priority to AU54781/98A priority patent/AU733561B2/en
Priority to ES98900270T priority patent/ES2223116T3/es
Priority to PL98334806A priority patent/PL334806A1/xx
Priority to RO99-00839A priority patent/RO120195B1/ro
Priority to DK98900270T priority patent/DK0966424T3/da
Priority to RU99118221/04A priority patent/RU2200153C2/ru
Priority to KR1019997006672A priority patent/KR100544046B1/ko
Priority to CA002278798A priority patent/CA2278798C/en
Priority to CNB988028301A priority patent/CN1188388C/zh
Priority to EP98900270A priority patent/EP0966424B1/en
Priority to HK00104495.2A priority patent/HK1025306B/xx
Priority to NZ336754A priority patent/NZ336754A/xx
Priority to AT98900270T priority patent/ATE269844T1/de
Priority to DE69824705T priority patent/DE69824705T2/de
Priority to PT98900270T priority patent/PT966424E/pt
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9701453.4A 1997-01-24 1997-01-24 Aminobenzophenones Pending GB9701453D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB9701453.4A GB9701453D0 (en) 1997-01-24 1997-01-24 Aminobenzophenones
PT98900270T PT966424E (pt) 1997-01-24 1998-01-08 Aminobenzofenonas como inibidores da interleucina e da fnt
RO99-00839A RO120195B1 (ro) 1997-01-24 1998-01-08 Aminobenzofenone ca inhibitori de interleukină şi tnf
RU99118221/04A RU2200153C2 (ru) 1997-01-24 1998-01-08 Аминобензофеноны, способ их получения, фармацевтический препарат, способ лечения и профилактики воспалительных заболеваний кожи
PCT/DK1998/000008 WO1998032730A1 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf
JP53149998A JP4250204B2 (ja) 1997-01-24 1998-01-08 インターロイキンおよびｔｎｆの阻害剤としてのアミノベンゾフェノン類
AU54781/98A AU733561B2 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and TNF
ES98900270T ES2223116T3 (es) 1997-01-24 1998-01-08 Aminobenzofenonas como inhibidores de interleucina y tnf.
PL98334806A PL334806A1 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf
US09/341,923 US6313174B1 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and TNF
DK98900270T DK0966424T3 (da) 1997-01-24 1998-01-08 Aminobenzophenoner som inhibitorer for interleukin og TNF
HU0000678A HUP0000678A3 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf, process for their preparation and pharmaceutical compositions containing the same
KR1019997006672A KR100544046B1 (ko) 1997-01-24 1998-01-08 인터류킨 및 ｔｎｆ의 억제제로서의 아미노벤조페논, 이의 제조방법 및 이를 함유하는 약제학적 제제
CA002278798A CA2278798C (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf
CNB988028301A CN1188388C (zh) 1997-01-24 1998-01-08 作为白介素和肿瘤坏死因子tnf抑制剂的氨基二苯酮
EP98900270A EP0966424B1 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf
HK00104495.2A HK1025306B (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitos of interleukin and tnf
NZ336754A NZ336754A (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and TNF
AT98900270T ATE269844T1 (de) 1997-01-24 1998-01-08 Aminobenzophenones als inhibitoren von interleukin und tnf
DE69824705T DE69824705T2 (de) 1997-01-24 1998-01-08 Aminobenzophenones als inhibitoren von interleukin und tnf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9701453.4A GB9701453D0 (en) 1997-01-24 1997-01-24 Aminobenzophenones

Publications (1)

Publication Number Publication Date
GB9701453D0 true GB9701453D0 (en) 1997-03-12

Family

ID=10806523

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9701453.4A Pending GB9701453D0 (en) 1997-01-24 1997-01-24 Aminobenzophenones

Country Status (19)

Country Link
US (1) US6313174B1 (https=)
EP (1) EP0966424B1 (https=)
JP (1) JP4250204B2 (https=)
KR (1) KR100544046B1 (https=)
CN (1) CN1188388C (https=)
AT (1) ATE269844T1 (https=)
AU (1) AU733561B2 (https=)
CA (1) CA2278798C (https=)
DE (1) DE69824705T2 (https=)
DK (1) DK0966424T3 (https=)
ES (1) ES2223116T3 (https=)
GB (1) GB9701453D0 (https=)
HU (1) HUP0000678A3 (https=)
NZ (1) NZ336754A (https=)
PL (1) PL334806A1 (https=)
PT (1) PT966424E (https=)
RO (1) RO120195B1 (https=)
RU (1) RU2200153C2 (https=)
WO (1) WO1998032730A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1210325B1 (en) 1999-07-16 2004-10-06 Leo Pharma A/S Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
RU2240995C2 (ru) * 1999-07-16 2004-11-27 Лео Фармасьютикал Продактс Лтд.А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) Аминобензофеноны в качестве ингибиторов интерлейкина il-1бета и фактора некроза опухолей tnf-альфа
AU768473B2 (en) * 1999-07-16 2003-12-11 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel aminobenzophenones
US6897236B1 (en) 1999-07-16 2005-05-24 Leo Pharmaceutical Products, Ltd. Aminobenzophenones as inhibitors of IL-1β and TNF-α
ES2228555T3 (es) * 1999-07-16 2005-04-16 Leo Pharma A/S Aminobenzofenonas con inhibidores de la il-1beta y tnf-alfa.
ATE277889T1 (de) * 1999-07-16 2004-10-15 Leo Pharma As Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
MXPA02005604A (es) * 1999-12-06 2004-09-10 Leo Pharma As Aminobenzofenonas como inhibidores de il-1beta y tnf-alfa.
CA2393027A1 (en) * 1999-12-17 2001-06-21 Abbott Laboratories Inhibitors of interleukin 5 gene expression
CA2394727A1 (en) * 1999-12-28 2001-07-05 Pharmacopeia, Inc. Pyrimidine and triazine kinase inhibitors
AU2001260081B2 (en) 2000-05-22 2005-07-28 Leo Pharma A/S Benzophenones as inhibitors of il-1beta and tnf-alpha
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
SE0100569D0 (sv) * 2001-02-20 2001-02-20 Astrazeneca Ab New compounds
GB0107368D0 (en) * 2001-03-23 2001-05-16 Novartis Ag Organic compounds
US20030073832A1 (en) * 2001-04-10 2003-04-17 Havez Sophie Elisabeth Novel aminophenyl ketone derivatives
KR100896667B1 (ko) * 2001-08-28 2009-05-14 레오 파마 에이/에스 신규한 아미노벤조페논 및 이를 포함하는 약제학적 조성물
PL377377A1 (pl) * 2002-12-20 2006-02-06 Leo Pharma A/S Nowe związki aminobenzofenonu
DK1658263T3 (da) * 2003-07-24 2010-09-27 Leo Pharma As Aminobenzophenonforbindelser
KR101260236B1 (ko) * 2004-12-13 2013-05-06 레오 파마 에이/에스 트리아졸 치환된 아미노벤조페논 화합물
DE102005022020A1 (de) * 2005-05-12 2006-11-23 Merckle Gmbh Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten
KR101057546B1 (ko) * 2007-06-05 2011-08-17 주식회사 엘지화학 광학 이방성 화합물 및 이를 포함하는 수지 조성물
EP2206534A1 (de) 2008-10-09 2010-07-14 c-a-i-r biosciences GmbH Dibenzocycloheptanonderivate und pharmazeutische Mittel, welche diese Verbindungen enthalten
WO2012167133A2 (en) * 2011-06-01 2012-12-06 The Regents Of The University Of California Inhibitors of anandamide transport and their therapeutic uses
WO2013028570A2 (en) 2011-08-19 2013-02-28 The Regents Of The University Of California Meta-substituted biphenyl peripherally restricted faah inhibitors
ES2908240T3 (es) 2014-04-07 2022-04-28 Univ California Inhibidores de la enzima amida hidrolasa de ácidos grasos (FAAH) con biodisponibilidad oral mejorada y su uso como medicamentos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1535401A (en) * 1977-07-28 1978-12-13 Holliday & Co Ltd L Nitrodiphenylamine carboxylic acid disperse dyes
SU790620A1 (ru) * 1979-06-01 1981-07-30 Ордена Трудового Красного Знамени Институт Медицинскойпаразитологии И Торпической Медицины Им.E.И.Марциновского Дихлор аминобензофенон как исходный продуктдл пОлучЕНи лЕКАРСТВЕННыХ пРЕпАРАТОВ C АНТигЕльМиНТНыМдЕйСТВиЕМ
JPH0776303B2 (ja) * 1986-11-21 1995-08-16 株式会社リコー 呈色性フタリド化合物及びその製造法及びこのものを発色成分とした記録材料

Also Published As

Publication number Publication date
JP2001511771A (ja) 2001-08-14
CN1248966A (zh) 2000-03-29
JP4250204B2 (ja) 2009-04-08
KR20000070437A (ko) 2000-11-25
CA2278798A1 (en) 1998-07-30
PL334806A1 (en) 2000-03-13
AU5478198A (en) 1998-08-18
CN1188388C (zh) 2005-02-09
KR100544046B1 (ko) 2006-01-23
ATE269844T1 (de) 2004-07-15
ES2223116T3 (es) 2005-02-16
RO120195B1 (ro) 2005-10-28
US6313174B1 (en) 2001-11-06
WO1998032730A1 (en) 1998-07-30
HUP0000678A2 (hu) 2001-10-28
CA2278798C (en) 2007-07-03
PT966424E (pt) 2004-09-30
HK1025306A1 (en) 2000-11-10
NZ336754A (en) 2001-03-30
RU2200153C2 (ru) 2003-03-10
HUP0000678A3 (en) 2001-11-28
DE69824705T2 (de) 2005-07-07
EP0966424B1 (en) 2004-06-23
DE69824705D1 (de) 2004-07-29
AU733561B2 (en) 2001-05-17
EP0966424A1 (en) 1999-12-29
DK0966424T3 (da) 2004-11-01

Similar Documents

Publication Publication Date Title
GB9701453D0 (en) Aminobenzophenones
MY158162A (en) 5-membered heterocycle-based p38 kinase inhibitors
MY147449A (en) 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
MXPA05013075A (es) Inhibidores de p-38 basados en heterociclo de 5 miembros.
EG24928A (en) Heterocyclic inhibitors of mek and methods of use thereof
MY121294A (en) Novel hexanoic acid derivatives.
GB9813540D0 (en) Chemical compounds
MY135856A (en) Nicotinamide derivatives useful as pde4 inhibitors
SG157231A1 (en) Substituted p-diaminobenzene derivatives
PL1601384T3 (pl) Sposoby radiofluorowania biologicznie czynnych wektorów
MXPA05013224A (es) Piridinilcarbamatos como inhibidores de lipasa sensible a hormonas.
ES2195785A1 (es) Nuevos derivados de piridazin-3(2h)-ona.
AU2004263179A8 (en) Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
YU6602A (sh) Pirimidin-2,4,6-trion metaloproteinazni inhibitori
YU35699A (sh) 2-amino-6-(2-supstituisan-4-fenoksi)-supstituisani piridini
TW200505865A (en) Compounds useful for the treatment of diseases
IL153147A0 (en) Phospholipid derivatives of valporic acid and mixtures thereof
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
MXPA02011858A (es) Inhibidores de adhesion de celula mediada por alfabeta2.
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
MXPA04005129A (es) Uso de diamina de acido piridin-2,4-dicarboxilico y de diaminas de acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de la colagenasa.
MXPA05010975A (es) Derivados de (6-(fenoxi)-pirido[3,4-d]pirimidin-2-il)-amina como inhibidores de p38 cinasa para el tratamiento de condiciones inflamatorias como artritis reumatoide.
ZA200609220B (en) Method of treating dry eye disorders and uveitis
MXPA04006085A (es) Compuestos de isocromano para el tratamiento de trastornos del sistema nervioso central.
BG108669A (bg) 2-амино-6-(2,4,5-заместени-фенил)-пиридини